Patents by Inventor Anne Nilsson

Anne Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA
    Publication number: 20190151376
    Abstract: A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.
    Type: Application
    Filed: October 30, 2018
    Publication date: May 23, 2019
    Inventors: Inger BJÖRCK, Anne NILSSON, Fredrik BACKHED, Petia KOVATCHEVA-DATCHARY
  • Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from
    Patent number: 10137157
    Abstract: A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: November 27, 2018
    Assignee: PROPREV AB
    Inventors: Inger Björck, Anne Nilsson, Fredrik Backhed, Petia Kovatcheva-Datchary
  • TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY
    Publication number: 20160113972
    Abstract: A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.
    Type: Application
    Filed: May 27, 2014
    Publication date: April 28, 2016
    Inventors: Inger BJÖRCK, Anne NILSSON, Fredrik BACKHED, Petia KOVATCHEVA-DATCHARY
  • CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
    Patent number: 9101609
    Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
    Type: Grant
    Filed: April 13, 2009
    Date of Patent: August 11, 2015
    Assignee: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
    Inventors: Philip Tan, Sandy A Simon, Charles G Cerveny, Christy Anne Nilsson, William Brady, Jeffrey A Ledbetter, Martha S Hayden-Ledbetter, Peter A Thompson, Cecile Morales
  • CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
    Publication number: 20140086903
    Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 27, 2014
    Inventors: Philip TAN, Charles G. Cerveny, Sandy A. Simon, Anne Nilsson, William Brady, Peter A. Thompson, Cecile Morales
  • FOOD PRODUCT COMPRISING RYE
    Publication number: 20140079833
    Abstract: A rye extract as well as food compositions including the extract. The use of the extract for the manufacture of a food composition, a dosage product, a pharmaceutical or a medicament. The extract is useful as a food composition, dosage product, pharmaceutical or medicament for the treatment, controlling or prevention of diseases or conditions related to metabolic syndrome, diabetes or obesity or in the promotion of satiety, weight loss or maintenance of desired body weight.
    Type: Application
    Filed: May 4, 2012
    Publication date: March 20, 2014
    Applicant: RYEFACTOR AB
    Inventors: Elin Ostman, Liza Rosen, Inger Bjorck, Anne Nilsson, Margareta Nyman
  • CD3 IMMUNOTHERAPEUTICS AND USES THEREOF
    Publication number: 20130195850
    Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.
    Type: Application
    Filed: November 15, 2012
    Publication date: August 1, 2013
    Applicant: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
    Inventors: Philip TAN, Sandy Alexander SIMON, Charles G. CERVENY, Christy Anne NILSSON, William BRADY, Jeffrey A. LEDBETTER, Martha Susan HAYDEN-LEDBETTER, Peter Armstrong THOMPSON, Cecile MORALES
  • CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
    Publication number: 20110171208
    Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.
    Type: Application
    Filed: April 11, 2009
    Publication date: July 14, 2011
    Applicant: TRUBION PHARMACEUTICALS, INC.
    Inventors: Philip Tan, Sandy Alexander Simon, Charles G. Cerveny, Christy Anne Nilsson, William Brady, Jeffrey A. Ledbetter, Martha Susan Hayden-Ledbetter, Peter Armstrong Thompson, Cecile Morales
  • CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
    Publication number: 20090274692
    Abstract: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
    Type: Application
    Filed: April 13, 2009
    Publication date: November 5, 2009
    Applicant: Trubion Pharmaceuticals, Inc.
    Inventors: Phillip Tan, Sandy A. Simon, Charles G. Cerveny, Christy Anne Nilsson, William Brady, Jeffrey A. Ledbetter, Martha S. Hayden-Ledbetter, Peter A. Thompson, Cecile Morales